Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …

Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Objective. Fatty liver is a rising global health concern, significantly increasing the burden of
health care cost. Nonalcoholic fatty liver disease (NAFLD) has a correlation with metabolic …

The key factor in preventing and treating nonalcoholic fatty liver disease (NAFLD) is a
holistic lifestyle modification approach, encompassing diet based on healthy eating patterns …

Advanced glycation end products (AGEs) may be associated with nonalcoholic fatty liver
disease (NAFLD) from stimulation of oxidative stress, inflammation, and fibrosis. We …

Nonalcoholic fatty liver disease (NAFLD) is caused by excessive liver lipid accumulation, but
insulin resistance is specifically associated with impaired lipid saturation, oxidation, and …

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) has been demonstrated to be
positively associated with serum advanced glycation end products (AGEs) and negatively …

Bone and the immune system are closely linked: bone regulates the hematopoietic stem
cells, which are precursors of immune cells, and several immunoregulatory cytokines …

This chapter discusses the role of dietary interventions in the treatment of nonalcoholic fatty
liver disease and nonalcoholic steatohepatitis. Within this section, the evidence in support of …

摘要目的: 探究总脂联素(total adiponectin, total APN) 和高分子量脂联素(high-molecular-
weight adiponectin, HMW APN) 与非酒精性脂肪性肝病(Nonalcoholic Fatty Liver Disease …